News
This Yoga Awareness Month, we’re highlighting the benefits of yoga for people living with lupus and sharing insights from two ...
8h
TipRanks on MSNAstraZeneca’s New Study on Anifrolumab: Implications for SLE Treatment
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca has initiated a study titled ‘A ...
Friends run for a cure for lupus, completing NYC Marathon in honor of longtime pal and lupus sufferer Rosie De Queljoe Herzog, 30, cheered on friends along the race route during ‘an emotional day’ ...
HopeHealth collaborates with BMS in phase 3 clinical trial for SLE treatment. Dr. Patel leads study to enhance lupus care ...
Treating Lupus: A Guide If you’ve been diagnosed with lupus, treatment is probably your biggest concern. Treating lupus is a team effort — so you and your doctors will work together to find the ...
A robust therapeutic pipeline and advancing research in revolutionary approaches like chimeric antigen receptor T-cell therapy have injected new hope into the lupus nephritis space. Meanwhile, ...
Saphnelo is approved for use in people with moderate to severe lupus who still have symptoms even though they are already taking other medicines to treat their overactive immune system.
The cause of lupus has long escaped doctors trying to treat the autoimmune disease. However, a study published this week identified a cause of lupus based on molecular defects in patients' blood ...
The New York City Walk with Us to Cure Lupus is the Lupus Research Alliance (LRA)'s signature national fundraising program, designed to increase awareness of lupus and raise crucial funds for ...
Lupus, a chronic inflammatory disease, occurs when an individual’s immune system attacks its tissues and organs. Inflammation caused by lupus can affect the joints, skin, kidneys, blood ...
It was a sea of purple as some 2,000 people took part in the Walk to Cure Lupus at the Intrepid on Pier 86.
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. AstraZeneca has launched a new observational study titled ‘Anifrolumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results